@receptorpharma.com
ReceptorPharma is a drug discovery company utilizing a completely new pathway to treat Alzheimer’s disease.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Receptor Pharma's primary focus is to secure funding in order to expand their IP portfolio, complete necessary non-clinical studies, and file for investigational new drug status with the FDA for RP301. This will enable them to begin their clinical study program. Investors have the opportunity to participate by purchasing Preferred Stocks at various price points, ranging from $500 to $9,000.
The company emphasizes transparency and provides a registration process for interested parties. Receptor Pharma is a private issuer publicly raising funds under Regulation D Rule 506(c), allowing them to advertise and accept investments from accredited investors. Their goal is to raise a total of $5 million through the sale of 50,000,000 Stocks priced at $0.
1 per Stock. Join Receptor Pharma in their groundbreaking mission to combat Alzheimer's Disease and make a meaningful impact in the pharmaceutical industry
Company Type
Privately Held
Company Size
2-10
Year Founded
2017
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online